Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
- DOI
- 10.1016/j.jacc.2024.03.405
- Published
- 2024 Jun 11
- Container
- Journal of the American College of Cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacc.2024.03.405,
title = {Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.},
author = {Udell JA and Petrie MC and Jones WS and Anker SD and Harrington J and Mattheus M and Seide S and Amir O and Bahit MC and Bauersachs J and Bayes-Genis A and Chen Y and Chopra VK and Figtree G and Ge J and Goodman SG and Gotcheva N and Goto S and Gasior T and Jamal W and Januzzi JL and Jeong MH and Lopatin Y and Lopes RD and Merkely B and Martinez-Traba M and Parikh PB and Parkhomenko A and Ponikowski P and Rossello X and Schou M and Simic D and Steg PG and Szachniewicz J and van der Meer P and Vinereanu D and Zieroth S and Brueckmann M and Sumin M and Bhatt DL and Hernandez AF and Butler J},
year = {2024},
journal = {Journal of the American College of Cardiology},
doi = {10.1016/j.jacc.2024.03.405},
url = {https://doi.org/10.1016/j.jacc.2024.03.405}
}RIS
TY - JOUR TI - Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction. AU - Udell JA AU - Petrie MC AU - Jones WS AU - Anker SD AU - Harrington J AU - Mattheus M AU - Seide S AU - Amir O AU - Bahit MC AU - Bauersachs J AU - Bayes-Genis A AU - Chen Y AU - Chopra VK AU - Figtree G AU - Ge J AU - Goodman SG AU - Gotcheva N AU - Goto S AU - Gasior T AU - Jamal W AU - Januzzi JL AU - Jeong MH AU - Lopatin Y AU - Lopes RD AU - Merkely B AU - Martinez-Traba M AU - Parikh PB AU - Parkhomenko A AU - Ponikowski P AU - Rossello X AU - Schou M AU - Simic D AU - Steg PG AU - Szachniewicz J AU - van der Meer P AU - Vinereanu D AU - Zieroth S AU - Brueckmann M AU - Sumin M AU - Bhatt DL AU - Hernandez AF AU - Butler J PY - 2024 JO - Journal of the American College of Cardiology DO - 10.1016/j.jacc.2024.03.405 UR - https://doi.org/10.1016/j.jacc.2024.03.405 ER -
APA
JA, U., MC, P., WS, J., SD, A., J, H., M, M., S, S., O, A., MC, B., J, B., A, B., Y, C., VK, C., G, F., J, G., SG, G., N, G., S, G., T, G., W, J., JL, J., MH, J., Y, L., RD, L., B, M., M, M., PB, P., A, P., P, P., X, R., M, S., D, S., PG, S., J, S., P, V. D. M., D, V., S, Z., M, B., M, S., DL, B., AF, H., & J, B. (2024). Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.03.405
Source records
- pubmed · retrieved 2026-09-26T16:43:40.715Z